Measuring spleen stiffness in veterans with fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests a new way to measure spleen stiffness in veterans with metabolic-dysfunction fatty liver disease. It may help doctors better understand and monitor this condition without invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand and agree to join this study
- You can read and understand English
- You have fatty liver disease confirmed by a past biopsy, scan, or doctor's note
- You are not pregnant
- You do not have severe liver damage (decompensated cirrhosis) or liver cancer
- You have your spleen
- You do not have a history of alcohol use disorder or drink more than 2 drinks a day (for women) or 3 drinks a day (for men)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
This study tests a new ultrasound method that measures spleen stiffness to help diagnose enlarged veins in the esophagus (esophageal varices) in people with chronic liver disease. It aims to find a less invasive way to detect these veins, which can cause serious bleeding.
This study tests a new, non-invasive way to measure liver stiffness using a device called FibroScan. It aims to make liver checkups easier and more comfortable for people with liver disease.
This study looks at whether measuring the stiffness of the spleen with a special ultrasound-like test (Fibroscan) can help doctors better understand and monitor PBC, a chronic liver disease. The goal is to see if this simple test can give useful information about how the disease is progressing.
This study tests whether a new scoring method can help doctors identify liver inflammation in patients who have both type 2 diabetes and a fatty liver. The goal is to find an easier, safer way to assess liver health without invasive procedures.
This study uses a special ultrasound device called iLivTouch to measure liver stiffness. It aims to see if changes in liver stiffness over time can predict serious liver problems in people with metabolic fatty liver disease. If you have MAFLD and your liver is already stiff, this could help doctors monitor your condition.
Hear when a new Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.